Clinical trial · Observational
Impact of COVID-19 on Lung Cancer Patients
Understanding the Physical, Social and Psychological Impact of COVID-19 on Frail and Shielded Lung Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
During the COVID-19 pandemic, people's lives have changed dramatically. People with lung cancer who are shielding may have been particularly affected as they may be unable to carry out many of their normal daily activities, such as grocery shopping and exercise, and are unable to interact with friends and family. People with lung cancer will also have experienced some changes to the clinical services available to them at The Christie. Using a questionnaire and interviews, the investigators want to understand patient experiences of the changes in their daily lives and the changes to their clinical care. This will help us to see if people with lung cancer need any additional support services or if there are any changes the investigators can make to clinical services to improve patient experiences. Eligible patients will be any lung cancer patients receiving current treatment or in active follow up.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Covid19 | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| PROM | — | UNRESOLVED | — |
| Psychological | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| questionnaire and optional interview | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- used electronic Patient Reported Outcome Measures
- description
- Lung cancer patients who have used the electronic Patient Reported Outcome Measures system before and after COVID-19 lock down or new patients who have completed their first electronic Patient Reported Outcome Measures after COVID-19 lock down.
- interventionNames
- Other: questionnaire and optional interview
- label
- never used electronic Patient Reported Outcome Measures
- description
- Lung cancer patients who have never completed electronic Patient Reported Outcome Measures.
- interventionNames
- Other: questionnaire and optional interview
Primary outcomes (2)
- measure
- Physical and Social impact
- timeFrame
- baseline
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) * patients in active treatment or in clinical follow-up Exclusion Criteria: * Lung cancer patients who do not speak or understand English will not be eligible to take part in the study * Patients under the age of 18 will be eligible for the study
References
Publications (0)
Data not yet available